Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PLx Pharma Inc.
  6. Summary
    PLXP   US72942A1079

PLX PHARMA INC.

(PLXP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
19.48(c) 19.38(c) 18.38(c) 18.69(c) 18.73(c) Last
375 815 979 592 887 845 365 669 509 804 Volume
-2.06% -0.51% -5.16% +1.69% +0.21% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5,73 M - -
Net income 2021 -27,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -14,2x
Yield 2021 -
Sales 2022 26,5 M - -
Net income 2022 -18,0 M - -
Net Debt 2022 - - -
P/E ratio 2022 -25,5x
Yield 2022 -
Capitalization 430 M 430 M -
Capi. / Sales 2021 75,1x
Capi. / Sales 2022 16,2x
Nbr of Employees 10
Free-Float 81,8%
More Financials
Company
PLx Pharma Inc. is a late-stage specialty pharmaceutical company. It is focusing on developing clinically-validated and patent-protected PLxGuard delivery system. Its lead product, Vazalore 325 mg, which is a formulation of aspirin using the PLxGuard delivery system intended to provide antiplatelet for cardiovascular disease prevention as compared to the current standard of care, enteric-coated aspirin, and... 
More about the company
Ratings of PLx Pharma Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PLX PHARMA INC.
07/27PLX PHARMA : to Make Vazalore Available in Over 2,400 Rite Aid Stores in August
MT
07/26PLX PHARMA : VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
AQ
07/26PLx Pharma Inc.’s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
CI
07/22PLX PHARMA : to Discuss 2021 Second Quarter Financial Results on August 6, 2021 ..
AQ
07/20AFTER HOURS WATCH LIST SCORECARD : Plxp, ppg, ardx
MT
07/20PLx Shares Rise as Walgreens Set to Carry Vazalore in Stores
DJ
07/20SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Tuesday
MT
07/20PLX PHARMA : JMP Securities Adjusts PLx Pharma's Price Target to $21 From $12, K..
MT
07/19MT NEWSWIRES AFTER HOURS WATCH LIST : Plxp, ppg, ardx
MT
07/19PLX PHARMA : Shares Up 15% on VAZALORE's Walgreens Launch
MT
07/19PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwid..
GL
07/15PLX PHARMA : Oppenheimer Adjusts PLx Pharma PT to $22 From $20, Maintains Outper..
MT
07/13AFTER HOURS WATCH LIST SCORECARD : Plxp, tyht, slp,
MT
07/13PLx Pharma Shares Up 30% as Vazalore Set To Launch in Walmart in August
DJ
07/13SECTOR UPDATE : Health Care Stocks Inch Lower Ahead of Tuesday Opener
MT
More news
News in other languages on PLX PHARMA INC.

- No features available -

More news
Analyst Recommendations on PLX PHARMA INC.
More recommendations
Chart PLX PHARMA INC.
Duration : Period :
PLx Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PLX PHARMA INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 18,73 $
Average target price 21,50 $
Spread / Average Target 14,8%
EPS Revisions
Managers and Directors
Natasha Giordano President, Chief Executive Officer & Director
Rita M. O'Connor CFO, Head-Manufacturing & Supply Chain
Michael J. Valentino Executive Chairman
Gary S. Balkema Independent Director
Kirk K. Calhoun Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PLX PHARMA INC.239.31%430
GILEAD SCIENCES, INC.19.86%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.33.61%68 112
REGENERON PHARMACEUTICALS20.70%59 505
VERTEX PHARMACEUTICALS-14.71%52 232